Ex Vivo Gene Therapy Clinical Trial for RDEB Using Genetically Corrected Autologous Skin Equivalent Grafts
Condition: Epidermolysis Bullosa Dystrophica, Recessive Intervention: Biological: COL7A1-SIN retroviral vector engineered autologous tissue-engineered skin Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials